Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05937295
Title FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined With Immune Checkpoint Inhibition (FusionVAC22)
Acronym FusionVAC22
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Hospital Tuebingen
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.